MPTP-induced Parkinson-like disease in sheep: Clinical and pathologic findings

A. M. Beale, Robert Higgins, T. M. Work, C. S. Bailey, M. O. Smith, T. Shinka, B. D. Hammock

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Eight ewes, divided into two groups based on age, with group 1 7-8 and group 2 1-3 years old, respectively, were administered 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) intravenously (IV) at cumulative doses of 2.0 to 34.6 mg/kg body weight. Two group 1 sheep, given cumulative doses of 2 and 8.5 mg/kg, developed persistent severe neurologic signs of body stiffness and rigidity, paucity of movement, intention body tremors, and abnormal body posture and stance similar to those signs in MPTP-induced disease in people and primates. After their acute onset, these persistent signs were nonprogressive up to the observation period of 32 days post infusion. None of the younger ewes had persistent neurologic symptoms at equivalent cumulative doses (9.0 mg/kg). The only pathologic changes were microscopic lesions in the central nervous system, consisting of bilaterally symmetrical neuronal chromatolysis and necrosis limited to the substantia nigra and locus ceruleus. These lesions were found in two persistently affected and two younger sheep, suggesting age-based differences in dose response and the threshold of clinical expression of disease. Serum MPTP half-life was 11 days. Thus sheep exposed to MPTP could be an alternative model to the primate for the comparative study of clinical, pathologic, and biochemical mechanisms in MPTP neurotoxicity and Parkinson's disease in people.

Original languageEnglish (US)
Pages (from-to)417-428
Number of pages12
JournalJournal of Environmental Pathology, Toxicology and Oncology
Volume9
Issue number5-6
StatePublished - 1989

Fingerprint

1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine
sheep
Parkinson Disease
Sheep
lesion
primate
Neurologic Manifestations
posture
Primates
nervous system
rigidity
half life
stiffness
serum
comparative study
Locus Coeruleus
Neurology
Tremor
Substantia Nigra
Posture

ASJC Scopus subject areas

  • Environmental Science(all)
  • Environmental Chemistry
  • Pathology and Forensic Medicine
  • Toxicology
  • Health, Toxicology and Mutagenesis

Cite this

Beale, A. M., Higgins, R., Work, T. M., Bailey, C. S., Smith, M. O., Shinka, T., & Hammock, B. D. (1989). MPTP-induced Parkinson-like disease in sheep: Clinical and pathologic findings. Journal of Environmental Pathology, Toxicology and Oncology, 9(5-6), 417-428.

MPTP-induced Parkinson-like disease in sheep : Clinical and pathologic findings. / Beale, A. M.; Higgins, Robert; Work, T. M.; Bailey, C. S.; Smith, M. O.; Shinka, T.; Hammock, B. D.

In: Journal of Environmental Pathology, Toxicology and Oncology, Vol. 9, No. 5-6, 1989, p. 417-428.

Research output: Contribution to journalArticle

Beale, AM, Higgins, R, Work, TM, Bailey, CS, Smith, MO, Shinka, T & Hammock, BD 1989, 'MPTP-induced Parkinson-like disease in sheep: Clinical and pathologic findings', Journal of Environmental Pathology, Toxicology and Oncology, vol. 9, no. 5-6, pp. 417-428.
Beale, A. M. ; Higgins, Robert ; Work, T. M. ; Bailey, C. S. ; Smith, M. O. ; Shinka, T. ; Hammock, B. D. / MPTP-induced Parkinson-like disease in sheep : Clinical and pathologic findings. In: Journal of Environmental Pathology, Toxicology and Oncology. 1989 ; Vol. 9, No. 5-6. pp. 417-428.
@article{5777e2f462ea413980df6e99c30c4507,
title = "MPTP-induced Parkinson-like disease in sheep: Clinical and pathologic findings",
abstract = "Eight ewes, divided into two groups based on age, with group 1 7-8 and group 2 1-3 years old, respectively, were administered 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) intravenously (IV) at cumulative doses of 2.0 to 34.6 mg/kg body weight. Two group 1 sheep, given cumulative doses of 2 and 8.5 mg/kg, developed persistent severe neurologic signs of body stiffness and rigidity, paucity of movement, intention body tremors, and abnormal body posture and stance similar to those signs in MPTP-induced disease in people and primates. After their acute onset, these persistent signs were nonprogressive up to the observation period of 32 days post infusion. None of the younger ewes had persistent neurologic symptoms at equivalent cumulative doses (9.0 mg/kg). The only pathologic changes were microscopic lesions in the central nervous system, consisting of bilaterally symmetrical neuronal chromatolysis and necrosis limited to the substantia nigra and locus ceruleus. These lesions were found in two persistently affected and two younger sheep, suggesting age-based differences in dose response and the threshold of clinical expression of disease. Serum MPTP half-life was 11 days. Thus sheep exposed to MPTP could be an alternative model to the primate for the comparative study of clinical, pathologic, and biochemical mechanisms in MPTP neurotoxicity and Parkinson's disease in people.",
author = "Beale, {A. M.} and Robert Higgins and Work, {T. M.} and Bailey, {C. S.} and Smith, {M. O.} and T. Shinka and Hammock, {B. D.}",
year = "1989",
language = "English (US)",
volume = "9",
pages = "417--428",
journal = "Journal of Environmental Pathology, Toxicology and Oncology",
issn = "0731-8898",
publisher = "Begell House Inc.",
number = "5-6",

}

TY - JOUR

T1 - MPTP-induced Parkinson-like disease in sheep

T2 - Clinical and pathologic findings

AU - Beale, A. M.

AU - Higgins, Robert

AU - Work, T. M.

AU - Bailey, C. S.

AU - Smith, M. O.

AU - Shinka, T.

AU - Hammock, B. D.

PY - 1989

Y1 - 1989

N2 - Eight ewes, divided into two groups based on age, with group 1 7-8 and group 2 1-3 years old, respectively, were administered 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) intravenously (IV) at cumulative doses of 2.0 to 34.6 mg/kg body weight. Two group 1 sheep, given cumulative doses of 2 and 8.5 mg/kg, developed persistent severe neurologic signs of body stiffness and rigidity, paucity of movement, intention body tremors, and abnormal body posture and stance similar to those signs in MPTP-induced disease in people and primates. After their acute onset, these persistent signs were nonprogressive up to the observation period of 32 days post infusion. None of the younger ewes had persistent neurologic symptoms at equivalent cumulative doses (9.0 mg/kg). The only pathologic changes were microscopic lesions in the central nervous system, consisting of bilaterally symmetrical neuronal chromatolysis and necrosis limited to the substantia nigra and locus ceruleus. These lesions were found in two persistently affected and two younger sheep, suggesting age-based differences in dose response and the threshold of clinical expression of disease. Serum MPTP half-life was 11 days. Thus sheep exposed to MPTP could be an alternative model to the primate for the comparative study of clinical, pathologic, and biochemical mechanisms in MPTP neurotoxicity and Parkinson's disease in people.

AB - Eight ewes, divided into two groups based on age, with group 1 7-8 and group 2 1-3 years old, respectively, were administered 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) intravenously (IV) at cumulative doses of 2.0 to 34.6 mg/kg body weight. Two group 1 sheep, given cumulative doses of 2 and 8.5 mg/kg, developed persistent severe neurologic signs of body stiffness and rigidity, paucity of movement, intention body tremors, and abnormal body posture and stance similar to those signs in MPTP-induced disease in people and primates. After their acute onset, these persistent signs were nonprogressive up to the observation period of 32 days post infusion. None of the younger ewes had persistent neurologic symptoms at equivalent cumulative doses (9.0 mg/kg). The only pathologic changes were microscopic lesions in the central nervous system, consisting of bilaterally symmetrical neuronal chromatolysis and necrosis limited to the substantia nigra and locus ceruleus. These lesions were found in two persistently affected and two younger sheep, suggesting age-based differences in dose response and the threshold of clinical expression of disease. Serum MPTP half-life was 11 days. Thus sheep exposed to MPTP could be an alternative model to the primate for the comparative study of clinical, pathologic, and biochemical mechanisms in MPTP neurotoxicity and Parkinson's disease in people.

UR - http://www.scopus.com/inward/record.url?scp=0024954987&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024954987&partnerID=8YFLogxK

M3 - Article

C2 - 2637935

AN - SCOPUS:0024954987

VL - 9

SP - 417

EP - 428

JO - Journal of Environmental Pathology, Toxicology and Oncology

JF - Journal of Environmental Pathology, Toxicology and Oncology

SN - 0731-8898

IS - 5-6

ER -